Recruiting

Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma

Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation

ClinicalTrials.gov IDNCT07529847
PhaseNA
Enrollment46
SponsorFoundation University Islamabad
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Asthma (Diagnosis)

About this study

Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Age between 18-45 years * Both genders (male and female) * Grade 1-3 on mMRC scale of dyspnea * Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020) Exclusion Criteria: * Patients having acute exerbation of COPD/status asthmaticus * Patients diagnosed with acute infection * Patients unable to follow command and instructions * Asthma patients with \>40sec control pause duration

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.